3 Idiopathic Thrombocytopenic Purpura Clinical Trials in New Orleans, LA (2026)

Q: How do I join a clinical trial in New Orleans?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you.

Recruiting Idiopathic Thrombocytopenic Purpura Studies in New Orleans

NCT06544499Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

The main purpose of this study is to look at the effect (efficacy) and safety of efgartigimod IV in participants with primary immune thrombocytopenia (ITP). After an up to 2 weeks screening period, el...

New Orleans, LAPHASE369 participantsargenx

View Study Details

NCT06721013Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

The purpose of the phase 1 part of this study is to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and sa...

New Orleans, LAPHASE168 participantsEli Lilly and Company

View Study Details

NCT07007962Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

This is a multinational, open label, single arm study that will evaluate the impact of early multi-immune modulation with rilzabrutinib in adult ITP patients who failed first-line treatment. The study...

New Orleans, LAPHASE360 participantsSanofi

View Study Details

About Idiopathic Thrombocytopenic Purpura Clinical Trials in New Orleans

Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.

There are currently 3 idiopathic thrombocytopenic purpura clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 197 participants. Research is being sponsored by argenx, Eli Lilly and Company, Sanofi. Clinical trial participation is free and participants receive study-related medical care at no cost.

Idiopathic Thrombocytopenic Purpura Clinical Trials in New Orleans — FAQ

Are there idiopathic thrombocytopenic purpura clinical trials in New Orleans?

Yes, there are 3 idiopathic thrombocytopenic purpura clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Orleans?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.

Are clinical trials in New Orleans free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.

What idiopathic thrombocytopenic purpura treatments are being tested?

The 3 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.

Data updated October 15, 2026 from ClinicalTrials.gov